2017年12月4日 |
Ito, M., Hayashi, K., Minamisawa, T., Homma, S., Koido, S. and Shiba, K. Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells. PLoS One, 12, e0188934 (2017) |
2017年11月10日 |
Yoshida, M., Hibino, K., Yamamoto, S., Matsumura, S., Yajima, Y. and Shiba, K. Preferential capture of EpCAM-expressing extracellular vesicles on solid surfaces coated with an aptamer-conjugated zwitterionic polymer. Biotechnol Bioeng, in press (2017) |
2017年10月23日 |
Tanaka, M., Yoshimoto, T. and Nakamura, T. A double-edged sword: the world according to Capicua in cancer. Cancer Sci., in press (2017) |
2017年9月26日 |
Osako, T., Iwase, T., Ushijima, M., Yonekura, R., Ohno, S. and Akiyama, F. A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients. Br. J. Cancer., in press (2017) |
2017年8月29日 |
Takemoto, A., Miyata, K. and Fujita, N. Platelet-activating factor podoplanin: from discovery to drug development. Cancer and metastasis reviews, 36, 225-234 (2017) |
2017年8月22日 |
Katayama, R. Therapeutic strategies and mechanisms of drug resistance in Anaplastic Lymphoma Kinase (ALK)-rearranged lung cancer. Pharmacol. Ther., 117, 1-8 (2017) |
2017年7月28日 |
Fuse, J. M., Okada, K., Oh-hara, T., Ogura, H., Fujita, N. and Katayama, R. Mechanisms of resistance to NTRK inhibitors and therapeutic strategies in NTRK1-rearranged cancers. Mol. Cancer Ther., 16, 2130-2143 (2017) |
2017年7月19日 |
Ogura, H., Nagatake-Kobayashi, Y., Adachi, J., Tomonaga, T., Fujita, N. and Katayama, R. TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity. Sci. Rep., 7, 5519 (2017) |
2017年7月13日 |
N. Tsuyama, R. Asaka, A. Dobashi, S. Baba, Y. Mishima, K. Ueda, M. Oguchi, H. Tsuji, K. hatake and K. Takeuchi. Epstein-Barr virus-negative extranodal “true” natural killer-cell lymphoma harbouring a KDM6A mutation. Hematol. Oncol., in press (2017) |
2017年6月23日 |
Miyata, K., Takemoto, A., Okumura, S., Nishio, M. and Fujita, N. Podoplanin enhances lung cancer cell growth in vivo by inducing platelet
aggregation. Sci. Rep., 7, 4059 (2017) |